MedTrace Logo

Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

NCT00025818 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 290

Last updated 2011-05-30

No results posted yet for this study

Summary

A six-month clinical research trial to evaluate the effectiveness of an investigational medication for the treatment of dry eye syndrome in patients that have been diagnosed with moderate to severe dry eye syndrome, an autoimmune disorder AND/OR females 65 years of age or older.

Conditions

  • Keratoconjunctivitis Sicca
  • Sjogren's Syndrome
  • Lupus Erythematosus, Systemic
  • Arthritis, Rheumatoid
  • Scleroderma, Systemic

Interventions

DRUG

Ophthalmic Emulsion

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-05-31
Primary Completion
2003-03-31
Completion
2003-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00025818 on ClinicalTrials.gov